Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
1.
Nat Methods ; 17(9): 947, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32728193

ABSTRACT

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

2.
Genes Brain Behav ; 18(1): e12514, 2019 01.
Article in English | MEDLINE | ID: mdl-30125473

ABSTRACT

The potential influence of pain on social behavior in laboratory animals has rarely been evaluated. Using a new assay of social behavior, the tube co-occupancy test (TCOT), we assess propinquity-the tendency to maintain close physical proximity-in mice exposed to pain using subcutaneous zymosan or spared nerve injury as noxious stimuli. Our previous experience with the TCOT showed that outbred mouse sibling dyads show higher levels of tube co-occupancy than stranger dyads. We find here that long-lasting pain from spared nerve injury given to both mice in the dyad abolishes this effect of familiarity, such that strangers also display high levels of propinquity. We performed a separate experiment to assess the effect on dominance behavior of nerve injury to one or both mice of a dyad in which relative dominance status had been previously established via the confrontation tube test. We find that neuropathic pain given only to the dominant mouse reverses the relationship in male but not female mice, such that the previously subordinate mouse becomes dominant. These observations bolster the scant but growing evidence that pain can robustly affect social behavior in animals.


Subject(s)
Chronic Pain/genetics , Genotype , Social Dominance , Animals , Chronic Pain/psychology , Female , Inbreeding , Male , Mice
3.
Chemosphere ; 218: 501-506, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30497033

ABSTRACT

Pyraclostrobin is a strobilurin fungicide that inhibits mitochondrial complex III of fungal and mammalian cells. In toxicity studies that were used to estimate the safety factor, pyraclostrobin was added to animal feed or to aqueous vehicles. However, foods containing residues of pyraclostrobin and other strobilurin fungicides (azoxystrobin, trifloxystrobin, fluoxastrobin) are frequently prepared in vegetable oil prior to human consumption. The primary objective of this study was to determine if pyraclostrobin dissolved in an oil-based vehicle had adverse health outcomes in mice when compared to aqueous-based vehicles. We found that pyraclostrobin does not fully dissolve in aqueous methyl cellulose (MC) or carboxymethyl cellulose (CMC), two vehicles used in industry-sponsored toxicity studies, but does fully dissolve in corn oil. Moreover, C57BL/6 mice receiving pyraclostrobin in corn oil displayed adverse health outcomes, including loss of body weight, hypothermia and diarrhea at lower doses than when added to feed or to aqueous vehicles. Our data suggest that previous studies underestimated the true toxicity of pyraclostrobin in mammals. Additional toxicity tests using oil-based vehicles are recommended to verify current safety recommendations for strobilurin fungicides.


Subject(s)
Fungicides, Industrial/administration & dosage , Fungicides, Industrial/toxicity , Strobilurins/administration & dosage , Strobilurins/toxicity , Administration, Oral , Animals , Carboxymethylcellulose Sodium/chemistry , Corn Oil , Drug Carriers/administration & dosage , Drug Carriers/chemistry , Male , Methylcellulose/chemistry , Mice, Inbred C57BL , Strobilurins/chemistry , Toxicity Tests , Water/chemistry
4.
Nat Methods ; 16(2): 206, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30584248

ABSTRACT

In the version of this Comment originally published, the authors omitted a funding source. Grant 5 P50 DA039841 (to E.J.C.) from the US National Institute on Drug Abuse has been added to the Acknowledgements in the HTML and PDF versions of the paper.

6.
Mol Pain ; 14: 1744806918763658, 2018.
Article in English | MEDLINE | ID: mdl-29546805

ABSTRACT

Grimace scales quantify characteristic facial expressions associated with spontaneous pain in rodents and other mammals. However, these scales have not been widely adopted largely because of the time and effort required for highly trained humans to manually score the images. Convoluted neural networks were recently developed that distinguish individual humans and objects in images. Here, we trained one of these networks, the InceptionV3 convolutional neural net, with a large set of human-scored mouse images. Output consists of a binary pain/no-pain assessment and a confidence score. Our automated Mouse Grimace Scale integrates these two outputs and is highly accurate (94%) at assessing the presence of pain in mice across different experimental assays. In addition, we used a novel set of "pain" and "no pain" images to show that automated Mouse Grimace Scale scores are highly correlated with human scores (Pearson's r = 0.75). Moreover, the automated Mouse Grimace Scale classified a greater proportion of images as "pain" following laparotomy surgery when compared to animals receiving a sham surgery or a post-surgical analgesic. Together, these findings suggest that the automated Mouse Grimace Scale can eliminate the need for tedious human scoring of images and provide an objective and rapid way to quantify spontaneous pain and pain relief in mice.


Subject(s)
Facial Expression , Nerve Net/physiopathology , Pain/diagnosis , Pain/physiopathology , Animals , Automation , Humans , Mice , Postoperative Care , Video Recording
7.
Proc Natl Acad Sci U S A ; 114(21): 5515-5520, 2017 05 23.
Article in English | MEDLINE | ID: mdl-28484016

ABSTRACT

Existing assays of social interaction are suboptimal, and none measures propinquity, the tendency of rodents to maintain close physical proximity. These assays are ubiquitously performed using inbred mouse strains and mutations placed on inbred genetic backgrounds. We developed the automatable tube cooccupancy test (TCOT) based on propinquity, the tendency of freely mobile rodents to maintain close physical proximity, and assessed TCOT behavior on a variety of genotypes and social and environmental conditions. In outbred mice and rats, familiarity determined willingness to cooccupy the tube, with siblings and/or cagemates of both sexes exhibiting higher cooccupancy behavior than strangers. Subsequent testing using multiple genotypes revealed that inbred strain siblings do not cooccupy at higher rates than strangers, in marked contrast to both outbred and rederived wild mice. Mutant mouse strains with "autistic-like" phenotypes (Fmr1-/y and Eif4e Ser209Ala) displayed significantly decreased cooccupancy.


Subject(s)
Inbreeding , Social Behavior , Animals , Female , Genotype , Male , Mice , Mice, Inbred Strains , Rats, Sprague-Dawley , Stress, Psychological
8.
Cell ; 166(2): 273-274, 2016 07 14.
Article in English | MEDLINE | ID: mdl-27419865

ABSTRACT

A study finds that deficits in touch-sensing somatosensory neurons contribute to social interaction and anxiety phenotypes in mouse models of autism and Rett syndrome. These findings suggest that some core symptoms of autism might originate from aberrant development or function of the peripheral nervous system.


Subject(s)
Autistic Disorder/genetics , Methyl-CpG-Binding Protein 2/genetics , Animals , Disease Models, Animal , Mice , Rett Syndrome/genetics , Touch
9.
Pain ; 156(12): 2616-2626, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26307858

ABSTRACT

Recent failures of clinical trials of novel analgesics designed to treat neuropathic pain have led to much speculation about the underlying reasons. One often discussed possibility is that the placebo response in these trials has increased in recent years, leading to lower separation between the drug and placebo arms. Whether this has indeed occurred has not yet been adequately addressed. Here, we extracted data from published randomized controlled trials (RCTs) of drugs for the treatment of chronic neuropathic pain over the years 1990 to 2013. We find that placebo responses have increased considerably over this period, but drug responses have remained stable, leading to diminished treatment advantage. This trend has been driven by studies conducted in the United States. Consideration of participant and study characteristics revealed that in the United States but not elsewhere, RCTs have increased in study size and length. These changes are associated with larger placebo response. Analysis of individual RCT time courses showed different kinetics for the treatment vs placebo responses, with the former evolving more quickly than the latter and plateauing, such that maximum treatment advantage was achieved within 4 weeks.


Subject(s)
Analgesics/therapeutic use , Chronic Pain/drug therapy , Neuralgia/drug therapy , Placebo Effect , Humans , Randomized Controlled Trials as Topic , United States
10.
Sci Transl Med ; 7(287): 287ra72, 2015 May 13.
Article in English | MEDLINE | ID: mdl-25972004

ABSTRACT

Chronic pain is a highly prevalent and poorly managed human health problem. We used microarray-based expression genomics in 25 inbred mouse strains to identify dorsal root ganglion (DRG)-expressed genetic contributors to mechanical allodynia, a prominent symptom of chronic pain. We identified expression levels of Chrna6, which encodes the α6 subunit of the nicotinic acetylcholine receptor (nAChR), as highly associated with allodynia. We confirmed the importance of α6* (α6-containing) nAChRs by analyzing both gain- and loss-of-function mutants. We find that mechanical allodynia associated with neuropathic and inflammatory injuries is significantly altered in α6* mutants, and that α6* but not α4* nicotinic receptors are absolutely required for peripheral and/or spinal nicotine analgesia. Furthermore, we show that Chrna6's role in analgesia is at least partially due to direct interaction and cross-inhibition of α6* nAChRs with P2X2/3 receptors in DRG nociceptors. Finally, we establish the relevance of our results to humans by the observation of genetic association in patients suffering from chronic postsurgical and temporomandibular pain.


Subject(s)
Chronic Pain/genetics , Receptors, Nicotinic/genetics , Receptors, Purinergic P2X2/metabolism , Receptors, Purinergic P2X3/metabolism , Animals , Down-Regulation , Fluorescence Resonance Energy Transfer , Ganglia, Spinal/metabolism , Humans , Mice , Mice, Mutant Strains , Purinergic P2X Receptor Antagonists/pharmacology
11.
Pain ; 155(10): 2063-70, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25093831

ABSTRACT

µ-Opioids remain vastly important for the treatment of pain, and would represent ideal analgesics if their analgesic effects could be separated from their many side effects. A recently synthesized compound, iodobenzoylnaltrexamide (IBNtxA), acting at 6-transmembrane (6-TM) splice variants of the µ-opioid receptor gene, was shown to have potent analgesic actions against acute, thermal pain accompanied by a vastly improved side-effect profile compared to 7-TM-acting drugs such as morphine. Whether such analgesia can be seen in longer-lasting and nonthermal algesiometric assays is not known. The current study demonstrates potent and efficacious IBNtxA inhibition of a wide variety of assays, including inflammatory and neuropathic hypersensitivity and spontaneous pain. We further demonstrate the dependence of such analgesia on 6-TM µ-opioid receptor variants using isobolographic analysis and the testing of Oprm1 (the µ-opioid receptor gene) exon 11 null mutant mice. Finally, the effect of nerve damage (spared nerve injury) and inflammatory injury (complete Freund's adjuvant) on expression of µ-opioid receptor variant genes in pain-relevant central nervous system loci was examined, revealing a downregulation of the mMOR-1D splice variant in the dorsal root ganglion after spared nerve injury. These findings are supportive of the potential value of 6-TM-acting drugs as novel analgesics.


Subject(s)
Analgesics, Opioid/therapeutic use , Exons , Naltrexone/analogs & derivatives , Pain/drug therapy , Protein Isoforms , Receptors, Opioid, mu/genetics , Analgesics, Opioid/pharmacology , Animals , Female , Hot Temperature , Male , Mice , Mice, Knockout , Naltrexone/pharmacology , Naltrexone/therapeutic use , Pain Threshold/drug effects
12.
Nat Methods ; 11(6): 629-32, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24776635

ABSTRACT

We found that exposure of mice and rats to male but not female experimenters produces pain inhibition. Male-related stimuli induced a robust physiological stress response that results in stress-induced analgesia. This effect could be replicated with T-shirts worn by men, bedding material from gonadally intact and unfamiliar male mammals, and presentation of compounds secreted from the human axilla. Experimenter sex can thus affect apparent baseline responses in behavioral testing.


Subject(s)
Analgesia , Olfactory Perception/physiology , Pain/physiopathology , Stress, Physiological , Animals , Female , Humans , Male , Mice , Pain/psychology , Pain Measurement , Rats
13.
Curr Top Behav Neurosci ; 20: 233-50, 2014.
Article in English | MEDLINE | ID: mdl-24557935

ABSTRACT

Pain elicits behaviors in humans and nonhuman animals that serve as social cues. Pain behaviors serve a communicative function in humans, and this may be true as well in other animals. This review considers the current evidence for modulation of acute pain in different social contexts in humans and rodents, with a focus on dyadic social interactions. Increasing data supports the ability of social buffering, emotional contagion (a form of empathy), vicarious learning, and social stress to modulate pain sensitivity and pain behavior in mice and rats. As in humans, many of these social factors operate, and affect pain, in a sex-dependent manner. The development of a true social neuroscience of pain, with detailed explication of the underlying neurochemistry and genetics, now seems achievable.

14.
J Neurosci ; 33(47): 18631-40, 2013 Nov 20.
Article in English | MEDLINE | ID: mdl-24259584

ABSTRACT

We report a novel model in which remote activation of peripheral nociceptive pathways in transgenic mice is achieved optogenetically, without any external noxious stimulus or injury. Taking advantage of a binary genetic approach, we selectively targeted Nav1.8(+) sensory neurons for conditional expression of channelrhodopsin-2 (ChR2) channels. Acute blue light illumination of the skin produced robust nocifensive behaviors, evoked by the remote stimulation of both peptidergic and nonpeptidergic nociceptive fibers as indicated by c-Fos labeling in laminae I and II of the dorsal horn of the spinal cord. A non-nociceptive component also contributes to the observed behaviors, as shown by c-Fos expression in lamina III of the dorsal horn and the expression of ChR2-EYFP in a subpopulation of large-diameter Nav1.8(+) dorsal root ganglion neurons. Selective activation of Nav1.8(+) afferents in vivo induced central sensitization and conditioned place aversion, thus providing a novel paradigm to investigate plasticity in the pain circuitry. Long-term potentiation was similarly evoked by light activation of the same afferents in isolated spinal cord preparations. These findings demonstrate, for the first time, the optical control of nociception and central sensitization in behaving mammals and enables selective activation of the same class of afferents in both in vivo and ex vivo preparations. Our results provide a proof-of-concept demonstration that optical dissection of the contribution of specific classes of afferents to central sensitization is possible. The high spatiotemporal precision offered by this non-invasive model will facilitate drug development and target validation for pain therapeutics.


Subject(s)
Afferent Pathways/metabolism , Optogenetics , Pain Threshold/physiology , Pain/pathology , Wakefulness/physiology , Afferent Pathways/pathology , Animals , Avoidance Learning/drug effects , Avoidance Learning/physiology , Cells, Cultured , Channelrhodopsins , Female , Ganglia, Spinal/cytology , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Hyperalgesia/genetics , Hyperalgesia/physiopathology , In Vitro Techniques , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Morphine/pharmacology , Morphine/therapeutic use , NAV1.8 Voltage-Gated Sodium Channel/genetics , Pain/drug therapy , Pain/genetics , Pain/physiopathology , Pain Threshold/drug effects , Receptors, Purinergic P2X3/metabolism , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/physiology , Valine/analogs & derivatives , Valine/pharmacology , Wakefulness/genetics , tau Proteins/genetics , tau Proteins/metabolism
15.
Pain ; 154(8): 1254-62, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23673147

ABSTRACT

Migraine is a highly prevalent, disabling and complex episodic brain disorder whose pathogenesis is poorly understood, due in part to the lack of valid animal models. Here we report behavioral evidence of hallmark migraine features, photophobia and unilateral head pain, in transgenic knock-in mice bearing human familial hemiplegic migraine, type 1 (FHM-1) gain-of-function missense mutations (R192Q or S218L) in the Cacna1a gene encoding the CaV2.1 calcium channel α1 subunit. Photophobia was demonstrated using a modified elevated plus maze in which the safe closed arms were brightly illuminated; mutant mice avoided the light despite showing no differences in the standard (anxiety) version of the test. Multiple behavioral measures suggestive of spontaneous head pain were found in 192Q mutants subjected to novelty and/or restraint stress. These behaviors were: (1) more frequent in mutant versus wildtype mice; (2) lateralized in mutant but not in wildtype mice; (3) more frequent in females versus males; and (4) dose-dependently normalized by systemic administration of 2 different acute analgesics, rizatriptan and morphine. Furthermore, some of these behaviors were found to be more frequent and severe in 218L compared to 192Q mutants, consistent with the clinical presentation in humans. We suggest that Cacna1a transgenic mice can experience migraine-related head pain and can thus serve as unique tools to study the pathogenesis of migraine and test novel antimigraine agents.


Subject(s)
Calcium Channels, L-Type/genetics , Functional Laterality/genetics , Headache/complications , Headache/genetics , Mutation/genetics , Photophobia/etiology , Stress, Psychological/etiology , Analgesics/therapeutic use , Animals , Calcium Channels, N-Type , Disease Models, Animal , Dose-Response Relationship, Drug , Feces , Female , Headache/drug therapy , Male , Mice , Mice, Transgenic , Morphine/therapeutic use , Pain Measurement , Triazoles/therapeutic use , Tryptamines/therapeutic use
16.
J Neurosci ; 31(43): 15450-4, 2011 Oct 26.
Article in English | MEDLINE | ID: mdl-22031891

ABSTRACT

The innate immune system is increasingly appreciated to play an important role in the mediation of chronic pain, and one molecule implicated in this process is the Toll-like receptor 4 (TLR4). Here, using pharmacological and genetic manipulations, we found that activating TLR4 in the spinal cord, with the agonist lipopolysaccharide (LPS), causes robust mechanical allodynia but only in male mice. Spinal LPS had no pain-producing effect in female mice. TLR4 also has a sex-specific role in inflammatory (complete Freund's adjuvant) and neuropathic (spared nerve injury) pain: pain behaviors were TLR4 dependent in males but TLR4 independent in females. The sex differences appear to be specific to the spinal cord, as LPS administered to the brain or the hindpaw produces equivalent allodynia in both sexes, and specific to pain, as intrathecal LPS produces equivalent hypothermia in both sexes. The involvement of TLR4 in pain behaviors in male mice is dependent on testosterone, as shown by gonadectomy and hormone replacement. We found no sex differences in spinal Tlr4 gene expression at baseline or after LPS, suggesting the existence of parallel spinal pain-processing circuitry in female mice not involving TLR4.


Subject(s)
Inflammation/pathology , Neuralgia/pathology , Sex Characteristics , Spinal Cord/metabolism , Toll-Like Receptor 4/metabolism , Analysis of Variance , Animals , Castration , Disease Models, Animal , Female , Gene Expression Regulation/drug effects , Gene Expression Regulation/genetics , Hyperalgesia , Inflammation/chemically induced , Inflammation/drug therapy , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mutation/genetics , Neuralgia/drug therapy , Neuralgia/etiology , Pain Measurement , Polysaccharides/administration & dosage , RNA, Messenger/metabolism , Spinal Cord/drug effects , Testosterone Propionate , Time Factors , Toll-Like Receptor 4/antagonists & inhibitors , Toll-Like Receptor 4/deficiency , Toll-Like Receptor 4/genetics , Zymosan/pharmacology
17.
Sci Transl Med ; 3(101): 101ra91, 2011 Sep 21.
Article in English | MEDLINE | ID: mdl-21937756

ABSTRACT

Provoked vestibulodynia, the most common form of vulvodynia (unexplained pain of the vulva), is a prevalent, idiopathic pain disorder associated with a history of recurrent candidiasis (yeast infections). It is characterized by vulvar allodynia (painful hypersensitivity to touch) and hyperinnervation. We tested whether repeated, localized exposure of the vulva to a common fungal pathogen can lead to the development of chronic pain. A subset of female mice subjected to recurrent Candida albicans infection developed mechanical allodynia localized to the vulva. The mice with allodynia also exhibited hyperinnervation with peptidergic nociceptor and sympathetic fibers (as indicated by increased protein gene product 9.5, calcitonin gene-related peptide, and vesicular monoamine transporter 2 immunoreactivity in the vaginal epithelium). Long-lasting behavioral allodynia in a subset of mice was also observed after a single, extended Candida infection, as well as after repeated vulvar (but not hind paw) inflammation induced with zymosan, a mixture of fungal antigens. The hypersensitivity and hyperinnervation were both present at least 3 weeks after the resolution of infection and inflammation. Our data show that infection can cause persistent pain long after its resolution and that recurrent yeast infection replicates important features of human provoked vulvodynia in the mouse.


Subject(s)
Candidiasis, Vulvovaginal/complications , Pain/etiology , Vagina/microbiology , Vulva/microbiology , Vulvodynia/complications , Animals , Candida albicans/physiology , Candidiasis, Vulvovaginal/microbiology , Candidiasis, Vulvovaginal/pathology , Disease Models, Animal , Female , Hyperalgesia/complications , Hyperalgesia/pathology , Inflammation/complications , Inflammation/pathology , Mice , Pain/pathology , Vagina/pathology , Vulva/innervation , Vulva/pathology , Vulvodynia/microbiology , Vulvodynia/pathology , Zymosan/administration & dosage , Zymosan/adverse effects
18.
Mol Pain ; 7: 55, 2011 Jul 29.
Article in English | MEDLINE | ID: mdl-21801409

ABSTRACT

We recently demonstrated the utility of quantifying spontaneous pain in mice via the blinded coding of facial expressions. As the majority of preclinical pain research is in fact performed in the laboratory rat, we attempted to modify the scale for use in this species. We present herein the Rat Grimace Scale, and show its reliability, accuracy, and ability to quantify the time course of spontaneous pain in the intraplantar complete Freund's adjuvant, intraarticular kaolin-carrageenan, and laparotomy (post-operative pain) assays. The scale's ability to demonstrate the dose-dependent analgesic efficacy of morphine is also shown. In addition, we have developed software, Rodent Face Finder®, which successfully automates the most labor-intensive step in the process. Given the known mechanistic dissociations between spontaneous and evoked pain, and the primacy of the former as a clinical problem, we believe that widespread adoption of spontaneous pain measures such as the Rat Grimace Scale might lead to more successful translation of basic science findings into clinical application.


Subject(s)
Facial Expression , Laboratories , Pain Measurement/methods , Pain/diagnosis , Analgesics/therapeutic use , Animals , Automation , Freund's Adjuvant , Mice , Morphine/therapeutic use , Nociceptors/metabolism , Pain/drug therapy , Rats , Rats, Wistar , Reproducibility of Results
19.
J Pain ; 12(1): 125-32, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20685172

ABSTRACT

UNLABELLED: We previously demonstrated that male mice display significantly reduced pain behavior on the acetic acid abdominal constriction test when confined in close proximity to a stranger male mouse. We show here the testosterone-dependence (via castration and testosterone propionate replacement) of this phenomenon, likely a form of (social) stress-induced analgesia. However, when similar male dyads are separated by vertical metal bars, allowing only partial physical contact, we find that the mice exhibit hyperalgesia, not analgesia, in response to both acetic acid injection and noxious radiant heat, relative to testing in isolation. This finding is specific to same-sex male dyads, and no change in nociceptive sensitivity is observed when males are tested in the presence of a female conspecific. We propose that pain sensitivity varies with respect to the severity of the social threat: mild social threat produces hyperalgesia and more severe social threat produces analgesia. PERSPECTIVE: This work highlights the importance of social threat in modulating pain behavior in a sex-specific manner. The findings add to a growing body of evidence that social factors affect pain behavior in mice, thus allowing the study of the mechanistic underpinnings of social modulation of pain in humans.


Subject(s)
Gonadal Steroid Hormones/administration & dosage , Interpersonal Relations , Pain Threshold/physiology , Pain/physiopathology , Pain/psychology , Animals , Behavior, Animal/drug effects , Behavior, Animal/physiology , Castration , Corticosterone/blood , Disease Models, Animal , Feces , Female , Male , Mice , Mice, Inbred ICR , Pain/drug therapy , Pain Measurement/methods , Pain Threshold/drug effects , Testosterone/therapeutic use
20.
Soc Neurosci ; 5(2): 163-70, 2010.
Article in English | MEDLINE | ID: mdl-19844845

ABSTRACT

It has been recently demonstrated that pain behavior in the mouse can be modulated by the presence of a conspecific, but what remains unclear is whether such pain behavior can serve the function of soliciting social approach. Using a novel social approach paradigm, we tested mice in various dyadic or triadic conditions, including "jailed" mice-some in pain via intraperitoneal injection of 0.9% acetic acid-and test mice free to approach or avoid the jailed mice. We observed a sex-specific effect whereby female, but not male, test mice approached a familiar same-sex conspecific in pain more frequently than an unaffected familiar or unfamiliar, but affected, conspecific. Despite a substantial literature emphasizing oxytocin's role in affiliative and pair-bonding behavior, this effect was also observed in female mice lacking the oxytocin receptor, suggesting that pain-related social approach may not be mediated by oxytocin. Furthermore, we found that the frequency of contact by the test mouse was negatively correlated with the pain behavior of the jailed mouse, suggesting that proximity of a familiar unaffected conspecific may have analgesic properties.


Subject(s)
Pain/physiopathology , Pain/psychology , Social Behavior , Social Perception , Acetic Acid/adverse effects , Analysis of Variance , Animals , Constriction , Disease Models, Animal , Female , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Pain/chemically induced , Receptors, Oxytocin/deficiency , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...